Region Skane Kristianstad Central Hospital

At Region Skane Kristianstad Central Hospital, clinical trials in Bacterial Infections and Mycoses focus on difficult-to-treat infections such as urinary tract infection, bacteremia, and Staphylococcus aureus bacteraemia. The research is aimed at improving treatment choices and finding effective ways to manage resistant or serious infections.

• Testing alternative oral treatment options for resistant urinary tract infections
• Comparing antibiotic strategies for penicillin-susceptible bloodstream infection
• Evaluating local antimicrobial approaches for diabetic foot ulcer healing

This work supports better infection control and more practical treatment pathways for patients with complex bacterial disease.

Trials in Cardiovascular Diseases and Hormonal diseases include research on atrial fibrillation with advanced chronic kidney disease, as well as studies in broader vascular risk and treatment safety. The goal is to improve stroke prevention and support safer care for people with severe kidney impairment and heart rhythm disorders.

• Assessing anticoagulation strategies to reduce stroke risk in advanced kidney disease
• Studying treatment safety and effectiveness in patients with major cardiovascular risk

The site’s Njursektionen contributes important clinical insight into how kidney disease intersects with heart disease in everyday care.

Research in Hormonal diseases and Immune System Diseases includes diabetes type 1 and diabetic foot ulcer. These trials are designed to understand disease control better, preserve insulin production, and improve healing outcomes for people living with diabetes-related complications.

• Exploring therapies that may help preserve natural insulin secretion in newly diagnosed type 1 diabetes
• Evaluating treatments intended to speed healing in diabetic foot ulcers

This research addresses both early disease management and the prevention of serious long-term complications.

Trials in Nervous System Diseases center on acute ischemic stroke and Facial Nerve Palsy. The main purpose is to test whether new or repurposed treatments can improve recovery after sudden neurological injury and support better functional outcomes for patients.

• Investigating treatment options to improve recovery after acute ischemic stroke
• Evaluating therapy to support nerve recovery in children with facial palsy

These studies reflect a strong interest in time-sensitive neurological care and rehabilitation.

The site also conducts trials in Respiratory Tract Diseases, Neoplasms, Immune System Diseases, and Virus Diseases. Main areas include chronic obstructive pulmonary disease, early triple negative breast cancer, EGFR-mutated non-small cell lung cancer, Crohn´s disease, ulcerative colitis, and giant cell arteritis, with additional work in inflammatory rheumatic disease.

• Testing whether new treatment combinations improve cancer response in breast and lung cancer
• Studying therapies that may reduce COPD exacerbations and related complications
• Looking at ways to maintain remission and guide treatment decisions in Crohn’s disease and ulcerative colitis
• Evaluating immune and anti-inflammatory treatment strategies for giant cell arteritis and rheumatic disease
• Examining how rheumatoid treatments affect response to RSV vaccination

Together, these studies show a broad focus on improving treatment effectiveness across chronic inflammatory disease, cancer, and respiratory illness.

Within Female Urogenital Diseases and Pregnancy Complications, the site is studying induction of labour. The research aims to compare care approaches and determine whether outpatient management can be as safe and effective as hospital-based care.

• Comparing outpatient and inpatient approaches to labour induction

This work is relevant to improving patient convenience while maintaining safety in maternity care.